Management of Persistent Meningoencephalitis

Evaluation and Treatment

• Persistent symptoms after 6 days of appropriate antibiotic therapy warrant reassessment of the treatment regimen and consideration of alternative approaches, according to the Journal of Infection guidelines 1
• For patients with no identified pathogen who have not clinically recovered by day 10, continued treatment is recommended, as suggested by the Journal of Infection 1
• Ensure meropenem is dosed appropriately at 2g IV every 8 hours for suspected ESBL-producing organisms, as recommended by the Journal of Infection 1
• Verify vancomycin dosing at 15-20 mg/kg IV every 12 hours with target trough levels of 15-20 μg/ml, as recommended by the Journal of Infection 1
• Consider adding rifampicin 600 mg twice daily if dealing with resistant pneumococcal infection, as suggested by the Journal of Infection 1
• For Enterobacteriaceae infections, continue treatment for 21 days, as recommended by the Journal of Infection and Praxis Medical Insights 1, 2
• The Infectious Diseases Society of America recommends treatment duration based on the pathogen, with 21 days for Enterobacteriaceae infections, 14 days for Streptococcus pneumoniae, 10 days for Haemophilus influenzae, and 21 days for Listeria monocytogenes 2
• Vancomycin should never be used alone due to concerns about CSF penetration, especially if dexamethasone has been administered, as warned by Praxis Medical Insights 2
• Inadequate treatment duration for gram-negative organisms, which typically require longer courses, is a common pitfall to avoid, as noted by Praxis Medical Insights 2
• Failure to adjust therapy based on antimicrobial susceptibility testing is another common pitfall, as cautioned by Praxis Medical Insights 2